Trial intelligence / Profile preview

Loss of jaw thrust response to assess adequate depth of anesthesia with remimazolam vs propofol

jRCT1031210554Recruiting

Start
Feb 2022
Modality
Small Molecules
Countries
1
01

Overview

Open-label trial of remimazolam and propofol (2 arms). Started Feb 2022; status: recruiting.

02

Drugs

remimazolampropofol

Beyond the preview

Go deeper on jRCT1031210554.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1031210554.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call